Search - tctmd.com

Displaying 581 - 600 of 1527

Sort: Relevancy | Date

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

News Daily News

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

March 01, 2019

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

News Daily News

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

Michael O'Riordan

March 01, 2019

DOACs Maintain Advantage Over Warfarin in A-fib Patients With Low Body Weight

News Daily News

DOACs Maintain Advantage Over Warfarin in A-fib Patients With Low Body Weight

February 25, 2019

When Is It Time to Abandon Thrombectomy for Acute Stroke? New Clues

News Daily News

When Is It Time to Abandon Thrombectomy for Acute Stroke? New Clues

February 25, 2019

Quality of CAD Care Varies by Type of Medicare Coverage

News Daily News

Quality of CAD Care Varies by Type of Medicare Coverage

February 20, 2019

Cilostazol-Based DAPT Safe, Effective in Patients at High Risk for Recurrent Stroke

News Conference News ISC 2019

Cilostazol-Based DAPT Safe, Effective in Patients at High Risk for Recurrent Stroke

February 12, 2019

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

News Features

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Michael O'Riordan

February 01, 2019

Is There a Volume-Outcome Relationship With Newer TAVR Valves? Maybe Not, Registry Suggests

News Daily News

Is There a Volume-Outcome Relationship With Newer TAVR Valves? Maybe Not, Registry Suggests

January 30, 2019

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

January 25, 2019

Late Follow-up of PFO Closure for Stroke Raises Questions for Antiplatelet Duration

News Daily News

Late Follow-up of PFO Closure for Stroke Raises Questions for Antiplatelet Duration

January 22, 2019

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

News Daily News

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

January 10, 2019

Tailoring Antiplatelet Therapy to Bleeding Risk Post-PCI Improves Outcomes and Cuts Costs, Model Suggests

News Daily News

Tailoring Antiplatelet Therapy to Bleeding Risk Post-PCI Improves Outcomes and Cuts Costs, Model Suggests

January 08, 2019

Rover’s Regurgitation: Veterinarian-Cardiologist Teamwork Could Speed Device Innovation, Training

News Features

Rover’s Regurgitation: Veterinarian-Cardiologist Teamwork Could Speed Device Innovation, Training

January 01, 2019

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

News Daily News

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

Michael O'Riordan

December 03, 2018

Bruises and Bumps: How Cardiology Meetings Survived the End of Direct Industry Sponsorship in Europe

News Features

Bruises and Bumps: How Cardiology Meetings Survived the End of Direct Industry Sponsorship in Europe

November 30, 2018

Metoclopramide May Mute Morphine’s Hampering of Ticagrelor Efficacy

News Daily News

Metoclopramide May Mute Morphine’s Hampering of Ticagrelor Efficacy

November 28, 2018

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

News Daily News

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

November 27, 2018

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

News Daily News

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

Michael O'Riordan

November 20, 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

Mortality Outcomes Similar Whether TAVR Performed in Hybrid OR or Cath Lab

News Daily News

Mortality Outcomes Similar Whether TAVR Performed in Hybrid OR or Cath Lab

Yael L. Maxwell

November 14, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.